Brimosun P 0.15% Eye Drop

Description

Brimosun P 0.15% Eye Drop is an ophthalmic solution used to treat open-angle glaucoma and ocular hypertension. It contains Brimonidine Tartrate (0.15%), an alpha-2 adrenergic agonist, which works by reducing the production of aqueous humor (fluid in the eye) and increasing its drainage, thereby lowering intraocular pressure (IOP). Managing high eye pressure is crucial to prevent optic nerve damage, which can lead to vision loss.

Key Features:

Active Ingredient: Contains Brimonidine Tartrate (0.15%), which lowers intraocular pressure by reducing fluid production in the eye and increasing its outflow.

Effective for Glaucoma and Ocular Hypertension: Formulated for patients with elevated IOP, Brimosun P helps protect against optic nerve damage and potential vision loss.

Quick and Long-lasting IOP Control: Provides fast relief by lowering eye pressure and maintaining control over time with regular use.

Convenient 5ml Bottle: Easy to carry and use, the 5ml dropper ensures convenient and consistent application.

How to Use:

Dosage: Instill one drop of Brimosun P 0.15% Eye Drop into the affected eye(s) two to three times daily, or as prescribed by your healthcare provider.

Application: Tilt your head back slightly, gently pull down the lower eyelid to create a small pocket, and squeeze the bottle to release a drop into the eye. Close your eye for a few seconds to ensure the medication is absorbed.

Avoid Contamination: Make sure the dropper tip does not touch any surface, including your eye, to prevent contamination of the solution.

Missed Dose: Apply the missed dose as soon as possible. If it’s almost time for your next dose, skip the missed one and resume your regular schedule. Avoid doubling doses.

Precautions:

Consult Your Doctor: Before using Brimosun P, inform your doctor if you have any history of cardiovascular disease, depression, or liver/kidney issues. Discuss all current medications you are taking, including other eye drops.

Contact Lenses: Remove contact lenses before applying the drops. Wait at least 15 minutes before reinserting them.

Possible Side Effects: Common side effects may include dry mouth, blurred vision, eye redness, and itching. Serious side effects, such as allergic reactions, eye pain, or severe vision changes, are rare but require immediate medical attention.

Who Should Use This Product:

Patients diagnosed with open-angle glaucoma or ocular hypertension who need to reduce and manage intraocular pressure.

Individuals who have been prescribed Brimonidine Tartrate by their eye care provider as part of their treatment plan for managing elevated IOP.

Conclusion:

Brimosun P 0.15% Eye Drop is a reliable and effective treatment for reducing intraocular pressure in patients with glaucoma or ocular hypertension. By lowering IOP, it helps protect the optic nerve and preserve vision. Regular use as directed by your healthcare provider will support healthy eye pressure and overall eye health.

Additional information